References
American Society for Testing and Materials. (2005). ASTM D6978-05 standard practice for assessment of resistance of medical gloves to permeation by chemotherapy drugs. West Conshohocken, PA: Author.
American Society of Health-System Pharmacists. (2006). ASHP guidelines on handling hazardous drugs. American Journal of Health-System Pharmacy, 63, 1172-1191. doi:10.2146/ajhp050529
American Society of Hospital Pharmacists. (1985). Technical assistance bulletin on handling cytotoxic drugs in hospitals. American Journal of Hospital Pharmacists, 42, 131-137.
Connor, T.H. (1993). An evaluation of the permeability of disposable polypropylene-based protective gowns to a battery of cancer chemotherapy drugs. Applied Occupational and Environmental Hygiene, 8, 785-789.
Falck, K., Gröhn, P., Sorsa, M., Vainio, H., Heinonen, E., & Holsti, L.R. (1979). Mutagenicity in urine of nurses handling cytostatic drugs. Lancet, 1, 1250-1251. doi:10.1016/S0140-6736(79)91939-1
Fransman, W., Roeleveld, N., Peelen, S., de Kort, W., Kromhout, H., & Heederik, D. (2007). Nurses with dermal exposure to antineoplastic drugs: Reproductive outcomes. Epidemiology, 18, 112-119.
Fuchs, J., Hengstler, J.G., Jung, D., Hiltl, G., Konietzko, J., & Oesch, F. (1995). DNA damage in nurses handling antineoplastic agents. Mutational Research, 342, 17-23. doi:10.1016/0165-1218(95)90086-1
Harrison, B.R. (2001). Risks of handling cytotoxic drugs. In M.C. Perry (Ed.), The chemotherapy source book (3rd ed., pp. 566-582.). Philadelphia, PA: Lippincott Williams and Wilkins.
Harrison, B.R., & Kloos, M.D. (1999). Penetration and splash protection of six disposable gown materials against fifteen antineoplastic drugs. Journal of Oncology Pharmacy Practice, 5, 61-66.
Kyprianou, M., Kapsou, M., Raftopoulos, V., & Soteriades, E.S. (2010). Knowledge, attitudes and beliefs of Cypriot nurses on the handling of antineoplastic agents. European Journal of Oncology Nursing, 14, 278-282. doi:10.1016/j.ejon.2010.01.025
Mahon, S.M., Casperson, D.S., Yackzan, S., Goodner, S., Hasse, B., Hawkins, J., … Witcher, V. (1994). Safe handling practices of cytotoxic drugs: The results of a chapter survey. Oncology Nursing Forum, 21, 1157-1165.
Martin, S. (2003). Chemotherapy handling and effects among nurses and their offspring (Unpublished doctoral dissertation). Columbia University, New York, NY.
Martin, S. (2005). Chemotherapy handling and effects among nurses and their offspring [Abstract]. Oncology Nursing Forum, 32, 425.
Martin, S., & Larson, E. (2003). Chemotherapy-handling practices of outpatient and office-based oncology nurses. Oncology Nursing Forum, 30, 575-581. doi:10.1188/03.ONF.575-581
McDiarmid, M.A., Oliver, M.S., Roth, T.S., Rogers, B., & Escalante, C. (2010). Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. Journal of Occupational and Environmental Medicine, 52, 1028-1034. doi:10.1097/JOM.0b013e3181f73ae6
National Institute for Occupational Safety and Health. (2004). Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. Retrieved from
http://www.cdc.gov/niosh/docs/2004-165/
Nieweg, R.M., de Boer, M., Dubbleman, R.C., Gall, H.E., Hesselman, G.M., Lenssen, P.C., … Slegt, J.H. (1994). Safe handling of antineoplastic drugs: Results of a survey. Cancer Nursing, 17, 501-511.
Occupational Safety and Health Administration. (1986). Guidelines for cytotoxic (antineoplastic) drugs (Publication No. 8-1.1). Washington, DC: Author.
Occupational Safety and Health Administration. (1996). Controlling occupational exposure to hazardous drugs. Occupational Safety and Health Administration. American Journal of Health-System Pharmacists, 53, 1669-1685.
Oncology Nursing Society. (1988). Cancer chemotherapy guidelines: Modules I-V. Pittsburgh, PA: Author.
Polovich, M. (2003). Safe handling of hazardous drugs. Pittsburgh, PA: Oncology Nursing Society.
Polovich, M., Whitford, J.M., & Olsen, M. (2009). Chemotherapy and biotherapy guidelines and recommendations for practice (3rd ed.). Pittsburgh, PA: Oncology Nursing Society.
Selevan, S.G., Lindbohm, M.L., Hornung, R.W., & Hemminki, K. (1985). A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. New England Journal of Medicine, 313, 1173-1178. doi:10.1056/NEJM198511073131901
Stajicj, G.V., Barnett, C.W., Turner, S.V., & Henderson, C.A. (1986). Protective measures used by oncologic office nurses handling parenteral antineoplastic agents. Oncology Nursing Forum, 13(6), 47-49.
Stücker, I., Caillard, J.F., Collin, R., Gout, M., Poyen, D., & Hémon, D. (1990). Risk of spontaneous abortion among nurses handling antineoplastic drugs. Scandinavian Journal of Work, Environment and Health, 16, 102-107.
Testa, A., Giachelia, M., Palma, S., Appolloni, M., Padua, L., Tranfo, G., … Cozzi, R. (2007). Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms. Toxicology and Applied Pharmacology, 223, 46-55. doi:10.1016/j.taap.2007.05.006
Valanis, B., McNeil, V., & Driscoll, K. (1991). Staff members' compliance with their facility's antineoplastic drug handling policy. Oncology Nursing Forum, 18, 571-576.
Valanis, B., & Shortridge, L. (1987). Self protective practices of nurses handling antineoplastic drugs. Oncology Nursing Forum, 14(3), 23-27.
Valanis, B., Vollmer, W., Labuhn, K., & Glass, A. (1997). Occupational exposure to antineoplastic agents and self-reported infertility among nurses and pharmacists. Journal of Occupational and Environmental Medicine, 39, 574-580. doi:10.1097/00043764-199706000-00013
Valanis, B., Vollmer, W.M., & Steele, P. (1999). Occupational exposure to antineoplastic agents: Self-reported miscarriages and stillbirths among nurses and pharmacists. Journal of Occupational and Environmental Medicine, 41, 632-638.
Valanis, B., Vollmer, W.M., Labuhn, K., Glass, A., & Corelle, C. (1992). Antineoplastic drug handling protection after OSHA guidelines. Comparison by profession, handling activity, and work site. Journal of Occupational Medicine, 34, 149-155.
Valanis, B.G., Vollmer, W.M., Labuhn, K.T., & Glass, A.G. (1993a). Acute symptoms associated with antineoplastic drug handling among nurses. Cancer Nursing, 16, 288-295.
Valanis, B.G., Vollmer, W.M., Labuhn, K.T., & Glass, A.G. (1993b). Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel. American Journal of Hospital Pharmacy, 50, 455-462.
Yoshida, J., Kosaka, H., Tomioka, K., & Kumagai, S. (2006). Genotoxic risks to nurses from contamination of the work environment with antineoplastic drugs in Japan. Journal of Occupational Health, 48, 517-522. doi:10.1539/joh.48.517